Concepts (100)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Extracorporeal Membrane Oxygenation | 5 | 2016 | 123 | 0.780 |
Why?
|
Streptokinase | 2 | 2005 | 23 | 0.470 |
Why?
|
Empyema, Pleural | 2 | 2005 | 13 | 0.470 |
Why?
|
Ant Venoms | 1 | 2013 | 8 | 0.430 |
Why?
|
Ants | 1 | 2013 | 21 | 0.430 |
Why?
|
Rhabdomyolysis | 1 | 2013 | 16 | 0.430 |
Why?
|
Respiratory Insufficiency | 3 | 2016 | 76 | 0.420 |
Why?
|
Anaphylaxis | 1 | 2013 | 43 | 0.420 |
Why?
|
Insect Bites and Stings | 1 | 2013 | 47 | 0.420 |
Why?
|
Fibrinolytic Agents | 2 | 2005 | 377 | 0.370 |
Why?
|
Heparin, Low-Molecular-Weight | 1 | 2010 | 41 | 0.370 |
Why?
|
Drug Monitoring | 1 | 2010 | 107 | 0.350 |
Why?
|
Acute Kidney Injury | 1 | 2013 | 232 | 0.350 |
Why?
|
Anticoagulants | 1 | 2010 | 356 | 0.300 |
Why?
|
Hepatic Encephalopathy | 1 | 2007 | 25 | 0.280 |
Why?
|
Liver Failure, Acute | 1 | 2007 | 49 | 0.280 |
Why?
|
Hyperglycemic Hyperosmolar Nonketotic Coma | 1 | 2006 | 4 | 0.270 |
Why?
|
Child, Preschool | 7 | 2013 | 3187 | 0.270 |
Why?
|
Intensive Care Units, Pediatric | 2 | 2010 | 101 | 0.260 |
Why?
|
Pleura | 1 | 2005 | 25 | 0.250 |
Why?
|
Hemolytic-Uremic Syndrome | 1 | 2004 | 9 | 0.230 |
Why?
|
Streptococcus pneumoniae | 1 | 2004 | 32 | 0.230 |
Why?
|
Pneumococcal Infections | 1 | 2004 | 30 | 0.220 |
Why?
|
Urokinase-Type Plasminogen Activator | 1 | 2003 | 26 | 0.210 |
Why?
|
Pleural Effusion | 1 | 2003 | 74 | 0.210 |
Why?
|
Pediatrics | 1 | 2005 | 341 | 0.200 |
Why?
|
Propofol | 1 | 2021 | 36 | 0.190 |
Why?
|
T-Lymphocytes | 1 | 2004 | 597 | 0.170 |
Why?
|
Infant | 4 | 2010 | 2891 | 0.140 |
Why?
|
Ketamine | 1 | 2016 | 57 | 0.120 |
Why?
|
Analgesics | 1 | 2016 | 118 | 0.120 |
Why?
|
Instillation, Drug | 2 | 2005 | 15 | 0.120 |
Why?
|
Survival Analysis | 2 | 2007 | 714 | 0.120 |
Why?
|
Humans | 14 | 2021 | 68618 | 0.110 |
Why?
|
Syndrome | 1 | 2013 | 255 | 0.100 |
Why?
|
Male | 7 | 2016 | 37321 | 0.100 |
Why?
|
Child | 5 | 2021 | 6405 | 0.100 |
Why?
|
Blood Coagulation Tests | 1 | 2010 | 31 | 0.090 |
Why?
|
Partial Thromboplastin Time | 1 | 2010 | 57 | 0.090 |
Why?
|
Jugular Veins | 1 | 2010 | 37 | 0.090 |
Why?
|
Hypoxia | 2 | 2016 | 169 | 0.090 |
Why?
|
Catheterization, Central Venous | 1 | 2010 | 89 | 0.090 |
Why?
|
Critical Illness | 1 | 2010 | 191 | 0.080 |
Why?
|
Hypnotics and Sedatives | 2 | 2021 | 96 | 0.080 |
Why?
|
Granulomatosis with Polyangiitis | 2 | 2005 | 11 | 0.080 |
Why?
|
Alprostadil | 1 | 2007 | 20 | 0.070 |
Why?
|
Plasmapheresis | 1 | 2007 | 18 | 0.070 |
Why?
|
Rare Diseases | 1 | 2007 | 41 | 0.070 |
Why?
|
Liver Function Tests | 1 | 2007 | 114 | 0.070 |
Why?
|
Female | 6 | 2010 | 38074 | 0.070 |
Why?
|
Fatal Outcome | 1 | 2006 | 164 | 0.070 |
Why?
|
Age Factors | 2 | 2007 | 1864 | 0.060 |
Why?
|
Combined Modality Therapy | 1 | 2007 | 951 | 0.060 |
Why?
|
Adolescent | 3 | 2010 | 8912 | 0.060 |
Why?
|
Catheterization | 1 | 2005 | 209 | 0.060 |
Why?
|
Status Epilepticus | 1 | 2004 | 74 | 0.060 |
Why?
|
Liver Transplantation | 1 | 2007 | 400 | 0.060 |
Why?
|
Anemia | 1 | 2004 | 104 | 0.050 |
Why?
|
Critical Care | 1 | 2005 | 263 | 0.050 |
Why?
|
Drainage | 1 | 2003 | 133 | 0.050 |
Why?
|
Lymphocyte Activation | 1 | 2004 | 397 | 0.050 |
Why?
|
Prognosis | 1 | 2007 | 2093 | 0.050 |
Why?
|
Length of Stay | 1 | 2005 | 780 | 0.050 |
Why?
|
Midazolam | 1 | 2021 | 46 | 0.050 |
Why?
|
Severity of Illness Index | 1 | 2007 | 1851 | 0.050 |
Why?
|
Conscious Sedation | 1 | 2021 | 61 | 0.050 |
Why?
|
Risk Assessment | 1 | 2007 | 2007 | 0.050 |
Why?
|
Retrospective Studies | 2 | 2021 | 7277 | 0.040 |
Why?
|
Obesity | 1 | 2006 | 1076 | 0.040 |
Why?
|
South Carolina | 1 | 2005 | 2752 | 0.040 |
Why?
|
Diabetes Mellitus, Type 2 | 1 | 2006 | 1085 | 0.040 |
Why?
|
Treatment Outcome | 2 | 2010 | 7029 | 0.030 |
Why?
|
Animals | 1 | 2013 | 20881 | 0.030 |
Why?
|
Hemorrhage | 2 | 2005 | 328 | 0.030 |
Why?
|
Magnetic Resonance Imaging | 1 | 2021 | 2223 | 0.030 |
Why?
|
Dose-Response Relationship, Drug | 1 | 2016 | 1745 | 0.030 |
Why?
|
Hospitals, Urban | 1 | 2010 | 46 | 0.020 |
Why?
|
Analgesics, Opioid | 1 | 2016 | 498 | 0.020 |
Why?
|
Pulmonary Gas Exchange | 1 | 2005 | 20 | 0.020 |
Why?
|
Pulmonary Alveoli | 1 | 2005 | 62 | 0.020 |
Why?
|
Nurse's Role | 1 | 2005 | 66 | 0.020 |
Why?
|
GABA Modulators | 1 | 2004 | 26 | 0.020 |
Why?
|
Spinal Puncture | 1 | 2004 | 38 | 0.020 |
Why?
|
Antibodies, Antineutrophil Cytoplasmic | 1 | 2004 | 10 | 0.020 |
Why?
|
Infant, Newborn | 1 | 2010 | 2455 | 0.010 |
Why?
|
Monitoring, Physiologic | 1 | 2005 | 219 | 0.010 |
Why?
|
Equipment Design | 1 | 2005 | 500 | 0.010 |
Why?
|
Follow-Up Studies | 1 | 2010 | 3259 | 0.010 |
Why?
|
Acute Disease | 1 | 2005 | 658 | 0.010 |
Why?
|
Radiography | 1 | 2004 | 572 | 0.010 |
Why?
|
Patient Care Team | 1 | 2005 | 311 | 0.010 |
Why?
|
Anticonvulsants | 1 | 2004 | 223 | 0.010 |
Why?
|
Prospective Studies | 1 | 2010 | 3705 | 0.010 |
Why?
|
Patient Selection | 1 | 2005 | 592 | 0.010 |
Why?
|
Practice Guidelines as Topic | 1 | 2005 | 772 | 0.010 |
Why?
|
Young Adult | 1 | 2010 | 5717 | 0.010 |
Why?
|
Middle Aged | 1 | 2016 | 21147 | 0.010 |
Why?
|
Adult | 2 | 2005 | 21403 | 0.010 |
Why?
|
Tomography, X-Ray Computed | 1 | 2005 | 2324 | 0.010 |
Why?
|
Brain | 1 | 2004 | 2176 | 0.010 |
Why?
|